{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:10:54Z","timestamp":1789650654323,"version":"4.0.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008571","name":"Southern Illinois University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","award":["Team Science Grant-2025"],"award-info":[{"award-number":["Team Science Grant-2025"]}],"id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"School of Medicine, Indiana University","doi-asserted-by":"publisher","award":["TSG-2025"],"award-info":[{"award-number":["TSG-2025"]}],"id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cytogfr.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:54:50Z","timestamp":1789253690000},"page":"101525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanism and clinical relevance of metabolic-immune cross-talk in pancreatic tumor microenvironment"],"prefix":"10.1016","volume":"92","author":[{"given":"Jonaid Ahmad","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Jatavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-6382","authenticated-orcid":false,"given":"Melissa L.","family":"Fishel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-1331","authenticated-orcid":false,"given":"Shailendra K.","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2026.08.005_bib1","article-title":"Siegel Rl, Soerjomataram I, Jemal A, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries - PubMed","volume":"74","author":"Bray","year":"2024"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib2","article-title":"Cancer statistics, 2026 - PubMed","volume":"76","author":"Siegel","year":"2026","journal-title":"CA a cancer journal clinicians"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib3","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy - PubMed","volume":"8","author":"Ju","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101547","article-title":"Is there a standard adjuvant therapy for resected pancreatic cancer? - PubMed","volume":"11","author":"Fenocchio","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib5","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminoncol.2018.12.002","article-title":"Neoadjuvant treatment for pancreatic cancer - PubMed","volume":"46","author":"Raufi Ag","year":"2019","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s13304-021-01186-1","article-title":"Neoadjuvant therapy for pancreatic cancer - PubMed","volume":"74","author":"Gugenheim","year":"2022","journal-title":"Updates Surg."},{"issue":"17","key":"10.1016\/j.cytogfr.2026.08.005_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174326","article-title":"Efficacy and safety of neoadjuvant gemcitabine plus nab-paclitaxel in borderline resectable and locally advanced pancreatic cancer-a systematic review and meta-analysis - PubMed","volume":"13","author":"Damm","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/ags3.12176","article-title":"Immunotherapy for pancreatic cancer: Barriers and breakthroughs - PubMed","volume":"2","author":"Torphy","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib9","article-title":"Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer - PubMed","volume":"1","author":"Ng","year":"2020"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib10","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy - PubMed","volume":"38","author":"As","year":"2020","journal-title":"Cancer Cell."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib11","article-title":"Immune checkpoint blockade in combination with stereotactic body radiotherapy in patients with metastatic pancreatic ductal adenocarcinoma - PubMed","volume":"26","author":"Xie","year":"2020","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32591-8","article-title":"The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma - PubMed","volume":"13","author":"Renouf","year":"2022","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.cytogfr.2026.08.005_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16234094","article-title":"Plasticity and tumor microenvironment in pancreatic cancer: genetic, metabolic, and immune perspectives - PubMed","volume":"16","author":"Hashimoto","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00081","article-title":"Metabolic symbiosis and immunomodulation: how tumor cell-derived lactate may disturb innate and adaptive immune responses - PubMed","volume":"8","author":"Morrot","year":"2018","journal-title":"Front. Oncol."},{"issue":"14","key":"10.1016\/j.cytogfr.2026.08.005_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191937","article-title":"Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception - PubMed","volume":"135","author":"Pedro","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-026-07880-1","article-title":"Mechanism of ASIC4 in regulating MHC-I-mediated immune evasion in pancreatic cancer - PubMed","volume":"24","author":"An","year":"2026","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01813-y","article-title":"Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma - PubMed","volume":"22","author":"Gautam","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000001621","article-title":"T-cell immunity in pancreatic cancer - PubMed","volume":"49","author":"Ajina","year":"2020","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib19","article-title":"Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib20","first-page":"9","article-title":"The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy","author":"Lim","year":"2020","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-021-10004-4","article-title":"Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets - PubMed","volume":"40","author":"Andersen","year":"2021","journal-title":"Cancer Metastas. Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.08.005_bib22","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.12.11.18140","article-title":"Tumor cell metabolism: an integral view - PubMed","volume":"12","author":"Romero-Garcia","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib23","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer - PubMed","volume":"48","author":"Luo","year":"2021","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib24","article-title":"Selective metabolic regulations by p53 mutant variants in pancreatic cancer - PubMed","volume":"43","author":"Caporali","year":"2024","journal-title":"J. Exper. Clini. Cancer Res. CR"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.08.005_bib25","doi-asserted-by":"crossref","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer - PubMed","volume":"32","author":"Stickler","year":"2024","journal-title":"Oncol. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism - PubMed","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.08.005_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-020-00315-1","article-title":"KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth - PubMed","volume":"2","author":"Raho","year":"2020","journal-title":"Nat. Metab."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.08.005_bib28","doi-asserted-by":"crossref","DOI":"10.15698\/cst2018.12.166","article-title":"The role of metabolic adaptation to nutrient stress in pancreatic cancer - PubMed","volume":"2","author":"Derle","year":"2018","journal-title":"Cell. Stress."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-021-00375-9","article-title":"Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment - PubMed","volume":"21","author":"Kerk","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.08.005_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web - PubMed","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05259-w","article-title":"Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma - PubMed","volume":"13","author":"Liu","year":"2022","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104844","article-title":"Novel insight into the Warburg effect: sweet temptation - PubMed","volume":"214","author":"Zhang","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02218-1","article-title":"The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy - PubMed","volume":"24","author":"Ma","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010245","article-title":"Glutamine-derived aspartate biosynthesis in cancer cells: role of mitochondrial transporters and new therapeutic perspectives - PubMed","volume":"14","author":"Gorgoglione","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102429","article-title":"KRAS mutation dictates the cancer immune environment in pancreatic ductal adenocarcinoma and other adenocarcinomas - PubMed","volume":"13","author":"Gu","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071872","article-title":"Molecular mechanisms and potential therapeutic reversal of pancreatic cancer-induced immune evasion - PubMed","volume":"12","author":"Gan","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer - PubMed","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2012.04.024","article-title":"Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia - PubMed","volume":"21","author":"Pylayeva-Gupta","year":"2012","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55718-2","article-title":"Colorectal cancers utilize glutamine as an anaplerotic substrate of the TCA cycle in vivo - PubMed","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.08.005_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy - PubMed","volume":"21","author":"Depeaux","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment - PubMed","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell."},{"issue":"32","key":"10.1016\/j.cytogfr.2026.08.005_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1501605112","article-title":"Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors - PubMed","volume":"112","author":"Daemen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.cytogfr.2026.08.005_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184351","article-title":"Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment - PubMed","volume":"14","author":"Yamamoto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep37594","article-title":"Autophagy is required for PDAC glutamine metabolism - PubMed","volume":"6","author":"Seo","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.08.005_bib45","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-17-0320","article-title":"The MiTF\/TFE family of transcription factors: master regulators of organelle signaling, metabolism, and stress adaptation - PubMed","volume":"15","author":"Slade","year":"2017","journal-title":"Molecular cancer research MCR"},{"issue":"7565","key":"10.1016\/j.cytogfr.2026.08.005_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/nature14587","article-title":"Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism - PubMed","volume":"524","author":"Perera","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib47","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00042.2019","article-title":"Microenvironmental determinants of pancreatic cancer - PubMed","volume":"100","author":"Hessmann","year":"2020","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00776-9","article-title":"Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions - PubMed","volume":"12","author":"Lin","year":"2020","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.08.005_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-326070","article-title":"Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment - PubMed","volume":"72","author":"Wang","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34081-3","article-title":"BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling - PubMed","volume":"13","author":"Shaashua","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-022-00530-w","article-title":"Epithelial and stromal co-evolution and complicity in pancreatic cancer - PubMed","volume":"23","author":"Hingorani","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-026-02620-x","article-title":"Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment - PubMed","volume":"25","author":"Ma","year":"2026","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/labinvest.3700377","article-title":"Expansion of mesenchymal stem cells from human pancreatic ductal epithelium - PubMed","volume":"86","author":"Seeberger","year":"2006","journal-title":"Lab. Investig. a J. Tech. Methods Pathol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib54","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-15-0947","article-title":"GM-CSF mediates mesenchymal-epithelial cross-talk in pancreatic cancer - PubMed","volume":"6","author":"Waghray","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0734-6","article-title":"Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 - PubMed","volume":"7","author":"Trovato","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours - PubMed","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib57","doi-asserted-by":"crossref","DOI":"10.18632\/aging.202264","article-title":"Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition - PubMed","volume":"13","author":"Xiong","year":"2021","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.08.005_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051119","article-title":"Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer - PubMed","volume":"12","author":"Cassim","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3119375","article-title":"Tumor Microenvironment: Lactic Acid Promotes Tumor Development - PubMed","volume":"2022","author":"Gao","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1034205","article-title":"Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival - PubMed","volume":"13","author":"Singh","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2011.02.011","article-title":"Decreased lactate dehydrogenase B expression enhances claudin 1-mediated hepatoma cell invasiveness via mitochondrial defects - PubMed","volume":"317","author":"Kim","year":"2011","journal-title":"Exp. Cell. Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04366-5","article-title":"Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenoma - PubMed","volume":"7","author":"An","year":"2017","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.cytogfr.2026.08.005_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163022","article-title":"Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer - PubMed","volume":"8","author":"Kitamura","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity - PubMed","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.08.005_bib65","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-20-0111","article-title":"Lactate-modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer - PubMed","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.08.005_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.1824","article-title":"Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8 - PubMed","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216784","article-title":"Tumor-associated macrophages drive glycolysis through the IL-8\/STAT3\/GLUT3 signaling pathway in pancreatic cancer progression - PubMed","volume":"588","author":"Zhong","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187024","article-title":"Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma - PubMed","volume":"135","author":"Sun","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191422","article-title":"Targeting lactylation and the STAT3\/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma - PubMed","volume":"135","author":"Chen","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: adenosine in tumor microenvironment - PubMed","volume":"7","author":"Ohta","year":"2016","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006457","article-title":"Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma - PubMed","volume":"11","author":"Graziano","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.08.005_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine - PubMed","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000186","article-title":"On the mechanism of anti-CD39 immune checkpoint therapy - PubMed","volume":"8","author":"Allard","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib74","article-title":"Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner - PubMed","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-025-00784-0","article-title":"The progress and prospects of targeting the adenosine pathway in cancer immunotherapy - PubMed","volume":"13","author":"Yang","year":"2025","journal-title":"Biomark. Res."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108871","article-title":"Targeting immunosuppressive adenosine signaling: a review of potential immunotherapy combination strategies - PubMed","volume":"24","author":"Zahavi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/med.70029","article-title":"Medicinal chemistry strategies for the development of CD73 Inhibitors in Cancer Immunotherapy - PubMed","volume":"46","author":"Cui","year":"2026","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000351","article-title":"Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer - PubMed","volume":"8","author":"Fujiwara","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI124077","article-title":"IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma - PubMed","volume":"129","author":"Blair","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1142838","article-title":"The immunomodulatory role of IDO1-Kynurenine-NAD+ pathway in switching cold tumor microenvironment in PDAC - PubMed","volume":"13","author":"Anu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01720","article-title":"NAD-biosynthetic and consuming enzymes as central players of metabolic regulation of innate and adaptive immune responses in cancer - PubMed","volume":"10","author":"Audrito","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012469118","article-title":"Dawson Dw, Radu Cg, Donahue Tr, NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition - PubMed","volume":"118","author":"Moore","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer - PubMed","volume":"20","author":"Leone","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib84","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-22-0876","article-title":"Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer - PubMed","volume":"13","author":"Falcomat\u00e0","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib85","article-title":"Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma - PubMed","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Experi. Clin. Cancer Res. CR"},{"issue":"14","key":"10.1016\/j.cytogfr.2026.08.005_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191940","article-title":"What's on the menu?: metabolic constraints in the pancreatic tumor microenvironment - PubMed","volume":"135","author":"Sheehan","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response - PubMed","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib88","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20180749","article-title":"predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma - PubMed, The","volume":"216","author":"Liu","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib89","article-title":"Metabolic reprogramming of immune cells in pancreatic cancer progression - PubMed","volume":"157","author":"Xiang","year":"2023","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2024.03.008","article-title":"Exploiting pancreatic cancer metabolism: challenges and opportunities - PubMed","volume":"30","author":"De Santis","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55424-2","article-title":"Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms - PubMed","volume":"16","author":"Sivakumar","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189183","article-title":"Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: molecular mechanisms and therapeutic targets - PubMed","volume":"1879","author":"Zhao","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib93","article-title":"Fatty acid metabolism of immune cells: a new target of tumour immunotherapy - PubMed","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib94","article-title":"T lymphocytes: a promising immunotherapeutic target for pancreatitis and pancreatic cancer? - PubMed","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2016.09.003","article-title":"T-cell immunometabolism against cancer - PubMed","volume":"382","author":"Jiang","year":"2016","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-024-01098-w","article-title":"Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer - PubMed","volume":"24","author":"Viel","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression - PubMed","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib98","doi-asserted-by":"crossref","unstructured":"Pc Ho, Jd Bihuniak, An Macintyre, M. Staron, X. Liu, R. Amezquita, Yc Tsui, G. Cui, G. Micevic, Jc Perales, Sh Kleinstein, Ed Abel, Kl Insogna, S. Feske, Jw Locasale, Mw Bosenberg, Jc Rathmell, Sm KaechPhosphoenolpyruvate is a metabolic checkpoint of anti-tumor t cell responses - PubMed2015Cell162.","DOI":"10.1016\/j.cell.2015.08.012"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib99","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function - PubMed","volume":"193","author":"Donnelly","year":"2014","journal-title":"J. Immun. (Baltimore Md. 1950"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib100","article-title":"Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions - PubMed","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib101","article-title":"Species-specific serine metabolism differentially controls natural killer cell functions - PubMed","volume":"7","author":"Li","year":"2025"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.08.005_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy - PubMed","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.cytogfr.2026.08.005_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213489","article-title":"Inhibition of glucose uptake blocks proliferation but not cytotoxic activity of NK Cells - PubMed","volume":"11","author":"Picard","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-022-01157-1","article-title":"Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer - PubMed","volume":"54","author":"Cui Zhou","year":"2022","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 Are an early driver of CD8(+) T cell exhaustion - PubMed","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082274","article-title":"Mechanisms of T-cell exhaustion in pancreatic cancer - PubMed","volume":"12","author":"Saka","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase - PubMed","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib108","article-title":"Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer - PubMed","volume":"182","author":"Tan","year":"2009","journal-title":"J. Immun. (Baltimore Md. 1950"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib109","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.12.038","article-title":"Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities - PubMed","volume":"156","author":"Balachandran","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib110","doi-asserted-by":"crossref","DOI":"10.1093\/bfgp\/ely006","article-title":"CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy - PubMed","volume":"18","author":"He","year":"2019","journal-title":"Brief. Funct. Genom."},{"issue":"19","key":"10.1016\/j.cytogfr.2026.08.005_bib111","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion - PubMed","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis - PubMed","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib113","article-title":"Macrophage infiltration and angiogenesis in human malignancy","author":"Helen","year":"2008","journal-title":"Novartis Found. Symp."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies - PubMed","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib115","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02481-w","article-title":"Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy - PubMed","volume":"24","author":"Coelho","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111590","article-title":"Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma - PubMed","volume":"129","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib117","article-title":"Macrophage-derived exosomal microRNA-501-3p p romotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-\u03b2 signaling pathway - PubMed","volume":"38","author":"Yin","year":"2019","journal-title":"J. Experi. Clin. Cancer Res. CR"},{"issue":"18","key":"10.1016\/j.cytogfr.2026.08.005_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17183090","article-title":"Strategies to target the tumor-associated macrophages in the immunosuppressive microenvironment of pancreatic ductal adenocarcinoma - PubMed","volume":"17","author":"Matsumoto","year":"2025","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib119","doi-asserted-by":"crossref","DOI":"10.7150\/jca.38981","article-title":"The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients - PubMed","volume":"11","author":"Hu","year":"2020","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages - PubMed","volume":"21","author":"Palsson-Mcdermott","year":"2015","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer - PubMed","volume":"167","author":"Kurahara","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00145","article-title":"Pyruvate kinase M2: a potential target for regulating inflammation - PubMed","volume":"7","author":"Alves-Filho","year":"2016","journal-title":"Front. Immunol."},{"issue":"75","key":"10.1016\/j.cytogfr.2026.08.005_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer - PubMed","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity - PubMed","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122838","article-title":"A pancreatic cancer organoid incorporating macrophages reveals the correlation between the diversity of tumor-associated macrophages and cancer cell survival - PubMed","volume":"314","author":"Tabe","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40895-6","article-title":"Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype - PubMed","volume":"14","author":"Oh","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607209","article-title":"Tumor-associated macrophages in pancreatic ductal adenocarcinoma: origin, polarization, function, and reprogramming - PubMed","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib128","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05307-3","article-title":"Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer - PubMed","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib129","article-title":"The role of regulatory T cells in cancer immunology - PubMed","volume":"4","author":"Whiteside","year":"2015","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.105076","article-title":"Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer - PubMed","volume":"218","author":"Guo","year":"2026","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106741","article-title":"Pillarisetty Vg, Fu D, FOXP3+ lymphocyte density in pancreatic cancer correlates with lymph node metastasis - PubMed","volume":"9","author":"Jiang","year":"2014","journal-title":"PloS. One"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091551","article-title":"An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma - PubMed","volume":"9","author":"Tang","year":"2014","journal-title":"PloS. One"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2017.06.062","article-title":"Crosstalk between regulatory T cells and tumor-associated dendritic cells negates anti-tumor immunity in pancreatic cancer - PubMed","volume":"20","author":"Jang","year":"2017","journal-title":"Cell. Rep."},{"issue":"15","key":"10.1016\/j.cytogfr.2026.08.005_bib134","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.191595","article-title":"Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia - PubMed","volume":"10","author":"Lyman","year":"2025","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib135","doi-asserted-by":"crossref","DOI":"10.1517\/14712598.2014.900539","article-title":"Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer - PubMed","volume":"14","author":"Chaudhary","year":"2014","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"16","key":"10.1016\/j.cytogfr.2026.08.005_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163862","article-title":"A paradoxical role for regulatory T cells in the tumor microenvironment of pancreatic cancer - PubMed","volume":"14","author":"Brouwer","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib137","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-19-0958","article-title":"Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis - PubMed","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib138","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity - PubMed","volume":"15","author":"Yan","year":"2022","journal-title":"J. Hematol. & Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib139","article-title":"cells trigger effector T cell DNA damage and senescence caused by metabolic competition - PubMed","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib140","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy - PubMed, Nature reviews","volume":"21","author":"Lasser","year":"2024","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1461455","article-title":"Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells - PubMed","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation - PubMed","volume":"7","author":"Deberardinis Rj","year":"2008","journal-title":"Cell. Metab."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.08.005_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control - PubMed","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib144","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000599","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-\u03b3, CXCL9 and CXCL10 - PubMed","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib145","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-21-0946","article-title":"Systemic alterations in type-2 conventional dendritic cells lead to impaired tumor immunity in pancreatic cancer - PubMed","volume":"11","author":"James","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2026.04.005","article-title":"Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer - PubMed","author":"Kureshi","year":"2026","journal-title":"Cancer Cell."},{"issue":"38","key":"10.1016\/j.cytogfr.2026.08.005_bib147","doi-asserted-by":"crossref","DOI":"10.2174\/09298673113206660290","article-title":"Effectivity of long antigen exposition dendritic cell therapy (LANEXDC\u00ae) in the palliative treatment of pancreatic cancer - PubMed","volume":"20","author":"Gansauge","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer - PubMed","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell."},{"issue":"6703","key":"10.1016\/j.cytogfr.2026.08.005_bib149","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh4567","article-title":"Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer - PubMed","volume":"384","author":"Mahadevan","year":"2024","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib150","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites - PubMed","volume":"196","author":"Terness","year":"2002","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib151","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11622","article-title":"Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review) - PubMed","volume":"22","author":"Elebo","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib152","article-title":"Indoleamine 2,3-dioxygenase 1 in cancer immunotherapy: from small-molecule inhibition to PROTAC-mediated degradation - PubMed","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1632446","article-title":"IDO and TDO inhibitors in cancer immunotherapy: mechanisms, clinical development, and future directions - PubMed","volume":"16","author":"Al-Zoubi","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.08.005_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.03.019","article-title":"Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells - PubMed","volume":"81","author":"Newman","year":"2021","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00508","article-title":"CD73's potential as an immunotherapy target in gastrointestinal cancers - PubMed","volume":"11","author":"Harvey","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib156","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells - PubMed","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol. (Baltimore Md. 1950"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib157","article-title":"IDO activates regulatory T cells and blocks their conversion into Th17-like T cells - PubMed","volume":"183","author":"Baban","year":"2009","journal-title":"J. Immunol. (Baltimore Md. 1950"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib158","article-title":"Metabolic classification suggests the GLUT1\/ALDOB\/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer - PubMed, Cell reports","volume":"4","author":"Li","year":"2023","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.08.005_bib159","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2021.2015321","article-title":"Glycometabolic rearrangements-aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential - PubMed","volume":"25","author":"Zhang","year":"2021","journal-title":"Expert. Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.08.005_bib160","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317699129","article-title":"The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas - PubMed","volume":"39","author":"Luo","year":"2017","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"issue":"5-6","key":"10.1016\/j.cytogfr.2026.08.005_bib161","article-title":"Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma - PubMed, Pathobiology","volume":"85","author":"Al-Zoughbi","year":"2018","journal-title":"J. Immunopathol. Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib162","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2069","article-title":"Zhu Wg, Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity - PubMed","volume":"12","author":"Zhao","year":"2010","journal-title":"Nat. Cell. Biol."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06207-y","article-title":"FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis - PubMed","volume":"14","author":"Wu","year":"2023","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1674163","article-title":"Endoplasmic reticulum stress orchestrates tumor metabolism and immunity: new insights into immunometabolic therapeutics - PubMed","volume":"16","author":"Fu","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.08.005_bib165","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-21-1022","article-title":"IFN\u03b1 Potentiates Anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment - PubMed","volume":"12","author":"Hu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2020.05.033","article-title":"Resolving the HIF paradox in pancreatic cancer - PubMed","volume":"489","author":"Fuentes","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/medsci13030190","article-title":"Advances in adoptive cell therapies in cancer: from mechanistic breakthroughs to clinical frontiers and overcoming barriers - PubMed","volume":"13","author":"Rabbani Sa","year":"2025","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41435-024-00315-1","article-title":"Hypoxia-induced autophagy in pancreatic cancer counteracts the cytotoxicity of CD8+ T cells by inhibiting the expression of MHC-I - PubMed","volume":"26","author":"Zhou","year":"2025","journal-title":"Genes. Immun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08609-0","article-title":"The RASSF1C-HIF-1\u03b1 axis drives macrophage lipid metabolism to promote pancreatic cancer - PubMed","volume":"17","author":"Zhan","year":"2026","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104016","article-title":"Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer - PubMed","volume":"79","author":"Ye","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib171","doi-asserted-by":"crossref","DOI":"10.1002\/jso.24627","article-title":"CAR T-cell therapy for pancreatic cancer - PubMed","volume":"116","author":"Deselm","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib172","article-title":"CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond - PubMed","volume":"23","author":"Chang","year":"2017"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061389","article-title":"Enhancing the efficacy of CAR T cells in the tumor microenvironment of pancreatic cancer - PubMed","volume":"12","author":"Henze","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib174","doi-asserted-by":"crossref","unstructured":"Sukumar M., Liu J., Mehta Gu, Patel Sj, Roychoudhuri R., Crompton Jg, Klebanoff Ca, Ji Y., Li P., Yu Z., Whitehill Gd, Clever D., Eil Rl, Palmer Dc, Mitra S., Rao M., Keyvanfar K., Schrump Ds, Wang E., \u2026, Restifo Np, Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy - PubMed, Cell metabolism 23(1) (01\/12\/2016).","DOI":"10.1016\/j.cmet.2015.11.002"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2017.06.002","article-title":"Editorial overview: metabolism of T cells: integrating nutrients, signals, and cell fate - PubMed","volume":"46","author":"Maciver","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells - PubMed","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.08.005_bib177","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2386","article-title":"Metabolic checkpoints in activated T cells - PubMed","volume":"13","author":"Wang","year":"2012","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib178","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01255-x","article-title":"Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells - PubMed","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1053120","article-title":"T-cell therapies against solid tumors: mechanisms and reversion of resistance - PubMed","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66102-2","article-title":"Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer - PubMed","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020275","article-title":"The oncoprotein mucin 1 in pancreatic cancer onset and progression: potential clinical implications - PubMed","volume":"15","author":"Dieli","year":"2025","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.08.005_bib182","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014199","article-title":"Commentary on \"Comparative efficacy and safety of PSCA CAR-engineered V\u03b41 \u03b3\u03b4 T cells for immunotherapy of pancreatic cancer\" - PubMed","volume":"14","author":"De Bont","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib183","doi-asserted-by":"crossref","DOI":"10.71150\/jm.2510017","article-title":"Development of tri-cistronic CLDN18.2 CAR-T cells incorporating PD-1\/CD28 switch and cyclophilin A for enhanced solid tumor immunotherapy - PubMed","volume":"64","author":"Lee","year":"2026","journal-title":"J. Microbiol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib184","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea2511","article-title":"KRASG12V\/HLA-A*02:01-targeted chimeric antigen receptor T cells exhibit potent preclinical activity against solid tumors - PubMed","volume":"12","author":"Shao","year":"2026","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.08.005_bib185","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. & Hepatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib186","doi-asserted-by":"crossref","DOI":"10.1097\/00006676-200410000-00002","article-title":"Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells - PubMed","volume":"29","author":"Apte","year":"2004","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib187","doi-asserted-by":"crossref","DOI":"10.1097\/00006676-200411000-00003","article-title":"The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma - PubMed","volume":"29","author":"Binkley","year":"2004","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib188","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2004.12.036","article-title":"Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells - PubMed","volume":"128","author":"Bachem","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib189","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-021-00271-4","article-title":"Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response - PubMed","volume":"7","author":"Wang","year":"2021","journal-title":"Cell. Discov."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib190","article-title":"CAR-T cell therapy for pancreatic cancer: translating emerging targets and dual-targeting strategies from solid tumors","volume":"17","author":"Shijun","year":"2026","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib191","article-title":"Mitochondrial metabolism in pancreatic ductal adenocarcinoma: from mechanism-based perspectives to therapy","volume":"15","author":"Hafiza","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors - PubMed","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.08.005_bib193","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-12-0348","article-title":"Desmoplasia: a response or a niche? - PubMed","volume":"2","author":"Declerck","year":"2012","journal-title":"Cancer Discov."},{"issue":"459","key":"10.1016\/j.cytogfr.2026.08.005_bib194","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7807","article-title":"The hallmarks of successful anticancer immunotherapy - PubMed","volume":"10","author":"Galluzzi","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.08.005_bib195","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2018-316595","article-title":"Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma - PubMed","volume":"68","author":"Raj","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1717062","article-title":"Reprogramming the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer - PubMed","volume":"16","author":"Hui","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib197","article-title":"Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy - PubMed","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"issue":"46","key":"10.1016\/j.cytogfr.2026.08.005_bib198","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v27.i46.7956","article-title":"T cells in pancreatic cancer stroma - PubMed","volume":"27","author":"Goulart","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib199","article-title":"CRISPR\/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook - PubMed","volume":"16","author":"Noormohamadi","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.08.005_bib200","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02513-5","article-title":"Gut microbiota reshaping the pancreatic cancer immune microenvironment: new avenues for immunotherapy - PubMed","volume":"24","author":"Zheng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.cytogfr.2026.08.005_bib201","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153563","article-title":"The effect of the gut microbiota on systemic and anti-tumor immunity and response to systemic therapy against cancer - PubMed","volume":"14","author":"Aghamajidi","year":"2022","journal-title":"Cancers"},{"issue":"40","key":"10.1016\/j.cytogfr.2026.08.005_bib202","article-title":"Integrating metabolic modulation and nanomedicine for cancer immunotherapy","volume":"12","author":"Xiaosu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib203","article-title":"Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives - PubMed","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.08.005_bib204","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297749","article-title":"pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model - PubMed","volume":"19","author":"Dutta","year":"2024","journal-title":"PloS. One"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib205","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.9b16209","article-title":"Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma - PubMed","volume":"12","author":"Wu","year":"2020","journal-title":"ACS Appl. Mater. & Interfaces"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2026.04.026","article-title":"A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer - PubMed","volume":"216","author":"Liu","year":"2026","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.08.005_bib207","doi-asserted-by":"crossref","DOI":"10.7150\/thno.64805","article-title":"Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies - PubMed","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120557","article-title":"Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy - PubMed","volume":"268","author":"Huang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2026.08.005_bib209","article-title":"Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives","volume":"17","author":"Xiaonan","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.08.005_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1501010","article-title":"Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy - PubMed","volume":"14","author":"Imani","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012600064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135961012600064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:35:16Z","timestamp":1789648516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135961012600064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":210,"alternative-id":["S135961012600064X"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.08.005","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism and clinical relevance of metabolic-immune cross-talk in pancreatic tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101525"}}